Panchsheel Organics Ltd.

197.00 +0.45 ▲0.2%

06 May 2024, 04:01:00 PM
Volume: 10,204

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.panchsheelorganics.com
Market Cap 259.48 Cr.
Enterprise Value(EV) 258.36 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 10.87 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 18.13 Trailing Twelve Months Ending 2023-12
Industry PE 42.15 Trailing Twelve Months Ending 2023-12
Book Value / Share 100.18 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.97 Calculated using Price: 197.00
Dividend Yield 1.83 Period Ending 2023-03
No. of Shares Subscribed 1.32 Cr. 13,171,750 Shares
FaceValue 10
About Panchsheel Organics Ltd.
Panchsheel Organics, incorporated in the year 1989, is a part of the Pharmaceutical Division of the Turakhia Brothers Group. Turakhia Brothers was founded in 1975 in the Mumbai, India. The Turakhia Group, promoters of the company, are engaged in the import-export trade of pharmaceutical raw materials since the past 25 years.

Panchsheel Organics Ltd. Delivery

Delivered Qty
Traded Qty

Panchsheel Organics Ltd. Performance

1 Day
+0.23%
1 Week
-3.31%
1 Month
-3.00%
3 Month
+1.57%
6 Month
+10.06%
1 Year
+10.27%
2 Year
-2.48%
5 Year
+526.99%
10 Year
+1541.67%

Panchsheel Organics Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 10.55 15.43 14.48 14.57 14.05 16.08 13.35 19.19 20.52
Return on Capital Employed (%) 14.28 18.51 19.66 18.21 17.77 20.31 18.6 24.61 25.61
Return on Assets (%) 5.55 8.66 8.43 8.55 8.76 10.79 8.94 12.43 14.1

Panchsheel Organics Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 19 21 23 27 30 35 40 47 96 102
Non Curr. Liab. 4 4 2 1 0 1 2 4 3 2
Curr. Liab. 11 12 14 19 15 17 17 24 26 33
Minority Int.
Equity & Liab. 33 37 39 47 45 53 59 75 124 137
Non Curr. Assets 7 9 10 10 9 11 15 13 46 52
Curr. Assets 26 28 29 37 36 42 45 62 78 86
Misc. Exp. not W/O
Total Assets 33 37 39 47 45 53 59 75 124 137

Panchsheel Organics Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 36 40 40 42 48 51 49 69 103 103
Other Income 0 0 0 0 0 0 0 0 1 4
Total Income 36 41 40 42 49 51 50 69 105 107
Total Expenditure -31 -35 -33 -36 -41 -42 -41 -56 -83 -85
PBIDT 5 6 7 7 7 9 9 13 21 22
Interest -1 -1 0 -1 0 0 0 0 -1 0
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -2 -2
Taxation -1 -1 -2 -2 -2 -2 -2 -3 -5 -5
Exceptional Items
PAT 2 3 3 4 4 5 5 8 14 14
Adjusted EPS 2 3 3 4 4 5 5 8 12 12

Panchsheel Organics Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 3 1 3 5 3 2 5 5 -2 0
Cash Fr. Inv. -1 -1 -2 -3 -1 -1 -3 -1 0 -34
Cash Fr. Finan. -2 0 -1 -1 -2 -2 -1 -2 -1 36
Net Change 0 0 -1 0 0 0 1 3 -2 1
Cash & Cash Eqvt 1 0 1 1 0 1 2 4 2 3

Panchsheel Organics Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 68.22 68.22 58.08 58.08 58.08 58.08 58.08 58.08 58.08
Public 31.78 31.78 41.92 41.92 41.92 41.92 41.92 41.92 41.92
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Panchsheel Organics Ltd. Announcements

Sat, 27 Apr 2024
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company PANCHSHEEL ORGANICS LTD.
2 CIN NO. L24232MP1989PLC005390
3 Report filed for FY 2023-2024
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* 0
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
8Quantum of (d) which has been met from (c)(e)* 0
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)0
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-Hitesh Singh Parihar
Designation :-Comany Secretary
Name of the Chief Financial Officer :- Deepak Natwarbhai Patel
Designation : -CFO

Date: 27/04/2024

Sat, 27 Apr 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyPANCHSHEEL ORGANICS LTD.
2CIN NO.L24232MP1989PLC005390
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.00
4Highest Credit Rating during the previous FY 0
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Hitesh Singh Parihar
Designation: Company Secretary
EmailId: compliance@panchsheelorganics.com
Name of the Chief Financial Officer: Gaurang Natwarbhai Patel
Designation: CFO
EmailId: accounts@panchsheelorganics.com

Date: 27/04/2024

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Wed, 24 Apr 2024
Certificate Under Regulation 40(9)
Certificate under Regulation 40(9)

Panchsheel Organics Ltd. Technical Scans

Fri, 03 May 2024
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Closing Below Previous Low for 2 Days Closing Below Previous Low for 2 Days
Making Lower Lows for 2 Days Making Lower Lows for 2 Days

Panchsheel Organics Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 361,915.69 1,529.55 +1.4%
Cipla Ltd. 115,033.60 1,423.40 -0.1%
Dr. Reddy's Laboratories Ltd. 105,928.76 6,293.45 -0.9%
Divi's Laboratories Ltd. 104,873.36 3,958.15 +0.2%
Zydus Lifesciences Ltd. 100,321.53 1,020.75 +2.3%
Mankind Pharma Ltd. 92,708.18 2,286.05 -1.2%
Torrent Pharmaceuticals Ltd. 92,483.60 2,720.45 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.64 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-12 31.02 1,423.40 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.26 6,293.45 -0.9%
Divi's Laboratories Ltd. Consolidated 2023-12 75.83 3,958.15 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 33.74 1,020.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-12 53.68 2,286.05 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 61.90 2,720.45 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.80 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-12 4.44 1,423.40 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.94 6,293.45 -0.9%
Divi's Laboratories Ltd. Consolidated 2023-12 8.05 3,958.15 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.32 1,020.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-12 10.44 2,286.05 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.93 2,720.45 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,423.40 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,293.45 -0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,958.15 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,020.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,286.05 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,720.45 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,423.40 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,293.45 -0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,958.15 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,020.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,286.05 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,720.45 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,423.40 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,293.45 -0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,958.15 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,020.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,286.05 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,720.45 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,423.40 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,293.45 -0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,958.15 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,020.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,286.05 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,720.45 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,423.40 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,293.45 -0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,958.15 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,020.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,286.05 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,720.45 -0.4%

Panchsheel Organics Ltd. FAQ's

What is Panchsheel Organics share price?

Can I buy Panchsheel Organics shares now?

What is the Dividend Yield of Panchsheel Organics?

What is the Market Cap of Panchsheel Organics?

What are the key metrics to analyse Panchsheel Organics?

What is the 52 Week High and Low of Panchsheel Organics?

What is the trend of Panchsheel Organics share price?